What they were paid
Damora Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $40,530 | — | $3,595 | — | $44,125 |
| FY2024 | $49,375 | — | $6,818 | — | $56,193 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Damora Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191429, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Damora Therapeutics pays directors a $40,000 cash retainer.
The rest of the Damora Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amy Wechsler | Independent Director | $46,258 |
| Cameron Turtle, D.Phil | Independent Director | — |
| Christopher Cain, Ph.D | Independent Director | $7,099 |
| Jennifer Jarrett | Director | $0 |
| Julianne Bruno | Independent Director | $8,594 |
| Michael Landsittel | Independent Director | — |
| Peter Harwin | Independent Director | $6,726 |
The full Damora Therapeutics compensation record
free company briefThis page is one director within Damora Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat